Immunotherapy News and Research

Latest Immunotherapy News and Research

Dendreon initiates enrollment in DN24-02 Phase 2 trial for HER2 positive cancer

Dendreon initiates enrollment in DN24-02 Phase 2 trial for HER2 positive cancer

FDA grants Advaxis pre-IND meeting for ADXS-HER2 cancer immunotherapy

FDA grants Advaxis pre-IND meeting for ADXS-HER2 cancer immunotherapy

NIH, Genesis Biopharma enter Patent License Agreement for adoptive cell therapy

NIH, Genesis Biopharma enter Patent License Agreement for adoptive cell therapy

CEL-SCI closes previously announced registered direct offering

CEL-SCI closes previously announced registered direct offering

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Immunotherapeutics for treatment of metastatic melanoma

Immunotherapeutics for treatment of metastatic melanoma

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

University of Groningen surgeons perform first fluorescence-guided ovarian cancer surgery

University of Groningen surgeons perform first fluorescence-guided ovarian cancer surgery

Novel therapies remove the brakes cancer puts on the immune system

Novel therapies remove the brakes cancer puts on the immune system

Generex issues update on Antigen Express spinout

Generex issues update on Antigen Express spinout

CRI announces winners of 2011 Coley Award for distinguished research in tumor immunology

CRI announces winners of 2011 Coley Award for distinguished research in tumor immunology

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Four-step plan for allergy sufferers to improve quality of life

Four-step plan for allergy sufferers to improve quality of life

Patients with sarcopenia more likely to have worse outcomes from melanoma

Patients with sarcopenia more likely to have worse outcomes from melanoma

PREVENT licenses Amorfix's ProMIS to develop vaccines against misfolded prion diseases

PREVENT licenses Amorfix's ProMIS to develop vaccines against misfolded prion diseases

Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease

Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease

Johns Hopkins establishes Center for Personalized Cancer Medicine with Commonwealth Foundation gift

Johns Hopkins establishes Center for Personalized Cancer Medicine with Commonwealth Foundation gift

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.